Padcev

Enfortumab Vedotin-Ejfv

7.7 High risk

Padcev & Neuropathy peripheral

15.7%

of users reported Neuropathy peripheral

99.1%

also reported Severe reaction

79.1%

are men

Most common medical consequences

Severe reaction
99.1%
Death
0.9%

Have you experienced any negative side effects from this medication?

Padcev: general information

Most common side effects (30)

Most commonly affected ages

50 - 59 years
3.4%
60 - 69 years
27.5%
70 - 79 years
52.1%
80 - 89 years
17.0%